HB 15 Delaware House · 152nd General Assembly (2023-2024)

AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO OVARIAN CANCER.

Summary
This Act requires all individual, blanket, and group health insurance policies to cover annual ovarian cancer screening tests for women at risk for ovarian cancer. It further expands the scope of monitoring tests available to women subsequent to ovarian cancer treatment.
Bill status signed all 5 stages cleared
Introduction
Feb 2024
Committee Review
Mar 2024
House Passage
Mar 2024
Senate Passage
Mar 2024
Signed into Law
Mar 2024
Introduced Feb 29, 2024 Signed Mar 21, 2024
Floor votes · Senate Mar 21, 2024 · House Mar 19, 2024

How they voted

200
Passed
Total votes 20
Mar 21, 2024
D Democratic14
14 Yea
100% Yea
R Republican6
6 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
9
Key actions
6
Committee
2
Amendments
2
Mar 21, 2024
Signed into law
Signed by Governor
executive
Mar 21, 2024
Upper · Passed
Passed By Senate. Votes: 21 YES
upper
Mar 20, 2024
Upper · Passed
Reported Out of Committee (Health & Social Services) in Senate with 7 Favorable
upper
Mar 19, 2024
Introduced
Assigned to Health & Social Services Committee in Senate
upper
Mar 19, 2024
Lower · Passed
Passed By House. Votes: 39 YES 2 ABSENT
lower
Mar 19, 2024
Lower · Passed
Amendment HA 1 to HB 15 - Passed In House by Voice Vote
lower
Mar 14, 2024
Introduced
Amendment HA 1 to HB 15 - Introduced and Placed With Bill
lower
Mar 13, 2024
Lower · Passed
Reported Out of Committee (Health & Human Development) in House with 10 Favorable, 2 On Its Merits
lower
Feb 29, 2024
Introduced
Introduced and Assigned to Health & Human Development Committee in House
lower
27 primary · 0 co-sponsors

Sponsors